Analysis-Pfizer could hold a Trump card in its bid for Metsera
By Michael Erman and Sabrina Valle (Reuters) -U.S. drugmaker Pfizer could work its connections withi...
31st October, 2025
By Michael Erman and Sabrina Valle (Reuters) -U.S. drugmaker Pfizer could work its connections withi...
31st October, 2025
By Manya Saini (Reuters) -Coinbase's first-mover advantage as the only publicly traded crypto exchan...
31st October, 2025
By Michael Holden and Sarah Young LONDON (Reuters) -Once widely reputed to be Queen Elizabeth's favo...
31st October, 2025
(Reuters) -Volkswagen's premium brand Audi lowered again its full-year profitability guidance on Fri...
31st October, 2025
ZURICH (Reuters) -The Swiss National Bank reported a third-quarter profit of 28.04 billion Swiss fra...
31st October, 2025
By Tom Balmforth LONDON (Reuters) -Russia has in recent months attacked Ukraine with a cruise missil...
31st October, 2025
(Reuters) -Mozambique's government may have counter-arguments to the updated budget and schedule pro...
31st October, 2025
A fundamental restructuring of middle-market financing has reshaped how companies access capital for...
31st October, 2025
By Florence Tan SINGAPORE (Reuters) -Oil prices eased on Friday, heading for a third straight monthl...
31st October, 2025
By Stephen Nellis, Akash Sriram and Kenrick Cai WASHINGTON (Reuters) -Apple Chief Executive Tim Cook...
31st October, 2025
By Stella Qiu SYDNEY (Reuters) -Asian shares are set for a seventh straight month of gains on Friday...
31st October, 2025
By Deborah Mary Sophia and Greg Bensinger (Reuters) -Amazon.com shares soared on Thursday after the...
30th October, 2025